ライフサイエンスコーパス: palmitoleic acid

1 oleic acid, but did contribute to growth on palmitoleic acid.

2 leic acid, while less than 10% were based on palmitoleic acid.

3 cells, enhancing the intracellular levels of palmitoleic acid.

4 l species, the lauric acid was replaced with palmitoleic acid.

5 their percentage concentrations of oleic and palmitoleic acids.

6 The monoenoic fatty acids palmitoleic acid (16:1 n-7) and oleic acid (18:1 n-9) we

7 levels of cholesterol ester and phospholipid palmitoleic acid (16:1) and oleic acid (18:1) and the le

8 ester myristic acid (14:0), and phospholipid palmitoleic acid (16:1), adrenic acid (22:4), and omega-

9 e revealed that recombinant SbDES2 converted palmitoleic acid (16:1Delta(9)) to hexadecadienoic acid

10 unguis-cati L.) vine accumulates nearly 80% palmitoleic acid (16:1Delta9) plus cis-vaccenic acid (18

11 fatty acid biomarkers [myristic acid (14:0), palmitoleic acid (16:1n-7), 7-hexadecenoic acid (16:1n-9

12 ids in the DNL pathway-palmitic acid (16:0), palmitoleic acid (16:1n-7), 7-hexadecenoic acid (16:1n-9

13 Palmitic acid (16:0), stearic acid (18:0), palmitoleic acid (16:1n-7), and oleic acid (18:1n-9) are

14 t, after adjustment for confounding factors, palmitoleic acid (16:1n-7; P = 2.8 x 10(-7)), dihomo-gam

15 er the serum cholesteryl ester proportion of palmitoleic acid [16:1n-7 (16:1omega-3)] and the ratio o

16 In secondary analyses, palmitoleic acid, 16:1n-7 (HR, 1.11; 95% CI, 1.02-1.21;

17 or lowest compared with highest quintiles of palmitoleic acid: 2.27; 95% CI: 1.52, 3.38; P for trend

18 on inhibitors carbenoxolone (100 microM) and palmitoleic acid (50 microM) did not affect vasorelaxati

19 ce that the UbiK-UbiJ complex interacts with palmitoleic acid, a major lipid in E. coli Last, in Salm

20 Oleic acid, linoleic acid, and palmitoleic acid also stimulated activity; however, satu

21 We report similarity between plasma palmitoleic acid and Crohn's disease and find that speci

22 association between plasma phospholipid cis- palmitoleic acid and heart failure risk in male physicia

23 warrants further research on adipose-derived palmitoleic acid and obesity risk.

24 ression of genes that direct biosynthesis of palmitoleic acid and omega3 fatty acids.

25 amined whether the effects of adipose tissue palmitoleic acid and SCD1 activity were associated with

26 esence of inhibitory concentrations of bile, palmitoleic acid, and the small molecule inhibitor virst

27 lerae, which is otherwise disrupted by bile, palmitoleic acid, and virstatin.

28 uct was observed with both palmitic acid and palmitoleic acid as substrates.

29 re is no direct evidence that adipose tissue palmitoleic acid behaves as a lipokine to reduce obesity

30 rom E. coli (mixed-spin) = 228 +/- 2 mV; for palmitoleic acid-bound BioI = -199 +/- 2 mV).

31 FA serum profiling revealed palmitoleic acid (C16:1n7) as a new molecular co-mediato

32 Animal experiments suggest that circulating palmitoleic acid (cis-16:1n-7) from adipocyte de novo fa

33 Palmitoleic acid (cis-16:1n-7), which is produced by end

34 positive association between adipose tissue palmitoleic acid concentrations and obesity (PR for lowe

35 The association between adipose tissue palmitoleic acid concentrations and obesity was attenuat

36 Studies in humans have evaluated only plasma palmitoleic acid concentrations, which reflect stearoyl-

37 accompanied by increases in plasma oleic and palmitoleic acid concentrations.

38 ately 75% suppression of the accumulation of palmitoleic acid, demonstrating that the physiologically

39 These apparent opposite effects of palmitoleic acid deserve further research in humans.

40 saturated TAGs containing oleic, linoleic or palmitoleic acids did not separate.

41 Palmitoleic acid ethyl ester (100 muM), an important med

42 Importantly, the palmitoleic acid ethyl ester-induced trypsin and proteas

43 stimulation and by the toxins bile acids and palmitoleic acid ethyl ester.

44 addition, wild type cells supplemented with palmitoleic acid exhibited an induction in PA phosphatas

45 ogenous fatty acids in the order of toxicity palmitoleic acid > oleic acid > palmitic acid.

46 Although plasma palmitoleic acid has been positively associated with blo

47 Changes in palmitoleic acid, however, did not reach significance wi

48 of Or47b neurons to a stimulatory pheromone, palmitoleic acid, is low in young males but high in olde

49 One site is dominated by a palmitoleic acid lipid group projecting from serine 187

50 nimal models have shown that adipose-derived palmitoleic acid may serve as a lipokine that contribute

51 with specific microbial metabolic pathways: palmitoleic acid metabolism and tryptophan degradation t

52 Other fatty acids including linolenic acid, palmitoleic acid, myristoleic acid, stearic acid, palmit

53 Palmitic:palmitoleic acid (n-7 saturation index) was inversely as

54 The levels of palmitoleic acid, oleic acid, and palmitoleic acid to pa

55 Palmitoleic acid (P = 0.010) and the ratio of 16:1n-7 to

56 11-2.25) across consecutive quartiles of cis-palmitoleic acid (P for trend 0.009).

57 ophosphatidylcholine (LPC), oleic acid (OA), palmitoleic acid (PA), arachidonic acid (AA), and mixed

58 The non-oxidative ethanol metabolites palmitoleic acid (POA) and POA-ethylester (POAEE) are re

59 eas was produced by injection of ethanol and palmitoleic acid (POA), a nonoxidative metabolite of eth

60 eam effector of 2AI-mediated AhR activation, palmitoleic acid protects RPE cells from 4HNE-mediated s

61 The finding that cis-palmitoleic acid reduces TCP and CT expression in V. cho

62 products of Ole1p catalysis, oleic acid and palmitoleic acid, suppress mga2Delta spt23-ts and mga2De

63 trans Palmitoleic acid (t-16:1n-7, or 16:1 t9 in the delta nom

64 tabilized by interactions of one hydrophobic palmitoleic acid tail with two CRD palmitoleoyl-binding

65 mutant were unaltered, although the ratio of palmitoleic acid to oleic acid was increased with a simi

66 levels of palmitoleic acid, oleic acid, and palmitoleic acid to palmitic acid (16:0) ratio were sign

67 omarkers pentadecanoic acid (15:0) and trans-palmitoleic acid (trans 16:1n-7) with type 2 diabetes tr

68 Plasma phospholipid concentrations of trans-palmitoleic acid (trans-16:1n-7), a biomarker of dairy f

69 Each SD increase in plasma cis-palmitoleic acid was associated with 17% higher odds of

70 We assessed whether plasma phospholipid cis-palmitoleic acid was associated with heart failure risk.

71 , the sensitivity of the pah1Delta mutant to palmitoleic acid was not rescued by the dgk1Delta mutati

72 fatty acids, EPA, and the SI for palmitic to palmitoleic acid were associated with significantly lowe

73 tadecylic acid (C15:0, an odd-chain SFA) and palmitoleic acid were inversely correlated with joint de

74 d cis-11-eicoseneic acids and an increase in palmitoleic acid were observed.

75 Unsaturated fatty acids (e.g., oleic and palmitoleic acids) were not subject to alpha oxidation,

76 of the Frizzled-4 (FZD4) CRD in complex with palmitoleic acid, which reveals a CRD tetramer consistin